Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2008 Aug 18;14:1517–1524.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Immunohistochemical analysis of VEGF-A_165b expression in the glaucomatous retina after five days of elevated IOP. A-C: Negative control. Non-specific staining was not detected in the retina. D-F: VEGF-A_165b staining of the normal retina (n=4). VEGF-A_165b was present in the RGC and the INL. G-I: VEGF-A_165b staining of the glaucomatous retina (n=4). VEGF-A_165b staining was stronger in the RGC and the INL compared to the normal retina. J-L: Negative control. No non-specific staining was observed in the retina. M-O: VEGF-A_165b staining of the RGC in the normal retina. Staining was colocalized with the RGC marker, Fluorogold. P-R: VEGF-A_165b staining of the RGC in the glaucomatous retina. Levels of VEGF-A_165b in the Fluorogold-labeled RGC (white arrow) were increased in the retinas with elevated IOP.